{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:51Z","timestamp":1790996811042,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0797-2","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T05:07:41Z","timestamp":1529730461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"Yuanxing","family":"Hang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-2187","authenticated-orcid":false,"given":"Xian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"key":"797_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76:17\u201328. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"797_CR2","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381. \n                    https:\/\/doi.org\/10.1002\/art.27584\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"797_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.7326\/0003-4819-139-8-200310210-00011","volume":"139","author":"EM Balk","year":"2003","unstructured":"Balk EM, Lau J, Goudas LC, Jordan HS, Kupelnick B, Kim LU, Karas RH. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med. 2003;139:670\u201382.","journal-title":"Ann Intern Med"},{"key":"797_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2009.01.004","volume":"206","author":"M Benn","year":"2009","unstructured":"Benn M. Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis. 2009;206:17\u201330. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.01.004\n                    \n                  .","journal-title":"Atherosclerosis"},{"key":"797_CR5","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1002\/art.21288","volume":"52","author":"CP Chung","year":"2005","unstructured":"Chung CP, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52:3045\u201353. \n                    https:\/\/doi.org\/10.1002\/art.21288\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"797_CR6","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.12659\/MSM.902536","volume":"23","author":"H Dai","year":"2017","unstructured":"Dai H, Zhang X, Yang Z, Li J, Zheng J. Effects of Baicalin on blood pressure and left ventricular remodeling in rats with Renovascular hypertension. Med Sci Monit. 2017;23:2939\u201348.","journal-title":"Med Sci Monit"},{"key":"797_CR7","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rincon","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737\u201345.","journal-title":"Arthritis Rheum"},{"key":"797_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2017.03.004","volume":"131","author":"B Dinda","year":"2017","unstructured":"Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017;131:68\u201380. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.004\n                    \n                  .","journal-title":"Eur J Med Chem"},{"key":"797_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03009740410006899","volume":"33","author":"N Erb","year":"2004","unstructured":"Erb N, Pace AV, Douglas KM, Banks MJ, Kitas GD. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2004;33:293\u20139. \n                    https:\/\/doi.org\/10.1080\/03009740410006899\n                    \n                  .","journal-title":"Scand J Rheumatol"},{"key":"797_CR10","unstructured":"Ferguson B (2014) ACSM\u2019s guidelines for exercise testing and prescription 9th Ed 2014. J Can Chiropractic Assoc 58:328\u2013328."},{"key":"797_CR11","doi-asserted-by":"publisher","first-page":"e3788","DOI":"10.1097\/MD.0000000000003788","volume":"95","author":"T Fleischer","year":"2016","unstructured":"Fleischer T, Chang TT, Chiang JH, Hsieh CY, Sun MF, Yen HR. Integration of Chinese herbal medicine therapy improves survival of patients with chronic lymphocytic leukemia: a Nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e3788. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000003788\n                    \n                  .","journal-title":"Medicine (Baltimore)"},{"key":"797_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00002281-200203000-00007","volume":"14","author":"N Goodson","year":"2002","unstructured":"Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol. 2002;14:115\u201320.","journal-title":"Curr Opin Rheumatol"},{"key":"797_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395. \n                    https:\/\/doi.org\/10.1056\/NEJMra043430\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"797_CR14","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1271\/bbb.50698","volume":"70","author":"WH Huang","year":"2006","unstructured":"Huang WH, Lee AR, Yang CH. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci Biotechnol Biochem. 2006;70:2371\u201380. \n                    https:\/\/doi.org\/10.1271\/bbb.50698\n                    \n                  .","journal-title":"Biosci Biotechnol Biochem"},{"key":"797_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1568006043586206","volume":"5","author":"Y Huang","year":"2005","unstructured":"Huang Y, Tsang SY, Yao X, Chen ZY. Biological properties of baicalein in cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:177\u201384.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"797_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.rdc.2010.02.002","volume":"36","author":"MJ Kaplan","year":"2010","unstructured":"Kaplan MJ. Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin N Am. 2010;36:405\u201326. \n                    https:\/\/doi.org\/10.1016\/j.rdc.2010.02.002\n                    \n                  .","journal-title":"Rheum Dis Clin N Am"},{"key":"797_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","volume":"55","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010;55:1209\u201316. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2009.10.053\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"key":"797_CR18","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/rheumatology\/ker232","volume":"50","author":"L Kozera","year":"2011","unstructured":"Kozera L, Andrews J, Morgan AW. Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation. Rheumatology (Oxford). 2011;50:1944\u201354. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ker232\n                    \n                  .","journal-title":"Rheumatology (Oxford)"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"H212","DOI":"10.1111\/j.1750-3841.2010.01755.x","volume":"75","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim GH. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. J Food Sci. 2010;75:H212\u20137. \n                    https:\/\/doi.org\/10.1111\/j.1750-3841.2010.01755.x\n                    \n                  .","journal-title":"J Food Sci"},{"key":"797_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/VHRM.S23113","volume":"7","author":"SJ Lewis","year":"2011","unstructured":"Lewis SJ. Lipid-lowering therapy: who can benefit? Vasc Health Risk Manag. 2011;7:525\u201334. \n                    https:\/\/doi.org\/10.2147\/VHRM.S23113\n                    \n                  .","journal-title":"Vasc Health Risk Manag"},{"key":"797_CR21","doi-asserted-by":"publisher","first-page":"e4904","DOI":"10.1097\/MD.0000000000004904","volume":"95","author":"JH Li","year":"2016","unstructured":"Li JH, et al. Bioactive components of Chinese herbal medicine enhance endogenous neurogenesis in animal models of ischemic stroke: a systematic analysis. Medicine (Baltimore). 2016;95:e4904. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000004904\n                    \n                  .","journal-title":"Medicine (Baltimore)"},{"key":"797_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.taap.2003.08.008","volume":"193","author":"AK Lund","year":"2003","unstructured":"Lund AK, Goens MB, Kanagy NL, Walker MK. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol Appl Pharmacol. 2003;193:177\u201387.","journal-title":"Toxicol Appl Pharmacol"},{"key":"797_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1756-185X.12999","volume":"20","author":"M Mahmoudi","year":"2017","unstructured":"Mahmoudi M, Aslani S, Fadaei R, Jamshidi AR. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. Int J Rheum Dis. 2017;20:287\u201397. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12999\n                    \n                  .","journal-title":"Int J Rheum Dis"},{"key":"797_CR24","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/rheumatology\/kev035","volume":"54","author":"GS Metsios","year":"2015","unstructured":"Metsios GS, et al. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford). 2015;54:2215\u201320. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kev035\n                    \n                  .","journal-title":"Rheumatology (Oxford)"},{"key":"797_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/art.25009","volume":"61","author":"YH Rho","year":"2009","unstructured":"Rho YH, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009;61:1580\u20135. \n                    https:\/\/doi.org\/10.1002\/art.25009\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"797_CR26","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957\u201363. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000099844.31524.05\n                    \n                  .","journal-title":"Circulation"},{"key":"797_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","volume":"6","author":"P Scicchitano","year":"2014","unstructured":"Scicchitano P, et al. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11\u201332. \n                    https:\/\/doi.org\/10.1016\/j.jff.2013.12.006\n                    \n                  .","journal-title":"J Funct Foods"},{"key":"797_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","volume":"11","author":"S Skeoch","year":"2015","unstructured":"Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11:390\u2013400. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2015.40\n                    \n                  .","journal-title":"Nat Rev Rheumatol"},{"key":"797_CR29","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35\u201361.","journal-title":"Clin Exp Rheumatol"},{"key":"797_CR30","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2889\u2013934. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.11.002\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"key":"797_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1385\/CT:2:4:263","volume":"2","author":"EA Thackaberry","year":"2002","unstructured":"Thackaberry EA, Gabaldon DM, Walker MK, Smith SM. Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia. Cardiovasc Toxicol. 2002;2:263\u201374.","journal-title":"Cardiovasc Toxicol"},{"key":"797_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1385\/CT:3:2:153","volume":"3","author":"A Vasquez","year":"2003","unstructured":"Vasquez A, Atallah-Yunes N, Smith FC, You X, Chase SE, Silverstone AE, Vikstrom KL. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc Toxicol. 2003;3:153\u201363.","journal-title":"Cardiovasc Toxicol"},{"key":"797_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1124\/jpet.114.215145","volume":"350","author":"HZ Wang","year":"2014","unstructured":"Wang HZ, et al. Inhibitory effect of baicalin on collagen-induced arthritis in rats through the nuclear factor-kappaB pathway. J Pharmacol Exp Ther. 2014;350:435\u201343. \n                    https:\/\/doi.org\/10.1124\/jpet.114.215145\n                    \n                  .","journal-title":"J Pharmacol Exp Ther"},{"key":"797_CR34","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/jphp.12484","volume":"67","author":"Y Xue","year":"2015","unstructured":"Xue Y, et al. Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor. J Pharm Pharmacol. 2015;67:1756\u201364. \n                    https:\/\/doi.org\/10.1111\/jphp.12484\n                    \n                  .","journal-title":"J Pharm Pharmacol"},{"key":"797_CR35","doi-asserted-by":"publisher","first-page":"268065","DOI":"10.1155\/2013\/268065","volume":"2013","author":"X Yang","year":"2013","unstructured":"Yang X, Yang J, Zou H. Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis. Clin Dev Immunol. 2013;2013:268065. \n                    https:\/\/doi.org\/10.1155\/2013\/268065\n                    \n                  .","journal-title":"Clin Dev Immunol"},{"key":"797_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1159\/000459708","volume":"41","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liao P, Zhu M, Li W, Hu D, Guan S, Chen L. Baicalin attenuates cardiac dysfunction and myocardial remodeling in a chronic pressure-overload mice model. Cell Physiol Biochem. 2017;41:849\u201364. \n                    https:\/\/doi.org\/10.1159\/000459708\n                    \n                  .","journal-title":"Cell Physiol Biochem"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0797-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T19:04:18Z","timestamp":1561230258000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0797-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,23]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the research committee of Wuxi No.2 People\u2019s Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have given consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"146"}}